SMAD3 and breast carcinoma: In breast cancer cells, inhibition of the Smad3/4 complex binding to the B3GALT4 promoter SBE can lead to the down-regulation of the B3GALT4 gene expression, which in turn hinders the epithelial-mesenchymal transition process in breast cancer cells (20).